⌘K
Loading ticker…
As of 2026-08-24, Anavex Life Sciences (AVXL) has a 3-month relative strength percentile of 75 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 44. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.5%, relative volume 0.52×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
AVXL is held by 15 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $1M notional. Top 3 carry $4M.
Held by 34 ETFs · $39M across latest filings · largest weight 0.32% (IBRN).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.01% | $1M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $1M | — |
| VHTVanguard Health Care ETF | 0.00% | $806K | — |
| SBIO | 0.18% | $289K | −0.08 pp |
| VTWG | 0.01% | $248K | — |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $209K |
| new |
| VTHRVanguard Russell 3000 ETF | 0.00% | $19K | — |
| IBBQ | 0.02% | $15K | — |
| ITWO | 0.01% | $12K | — |
| MSSM | 0.00% | $11K | — |
Showing 10 of 15 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AVXL Jan avg: -0.04% median: 1.85% win: 50% σ: 30.56% n: 4 2022-04-12 → 2026-07-31 | AVXL Feb avg: -11.68% median: -13.16% win: 0% σ: 4.07% n: 4 2022-04-12 → 2026-07-31 | AVXL Mar avg: -8.29% median: -5.48% win: 25% σ: 16.73% n: 4 2022-04-12 → 2026-07-31 | AVXL Apr avg: -7.60% median: -5.02% win: 40% σ: 18.13% n: 5 2022-04-12 → 2026-07-31 | AVXL May avg: 0.16% median: 6.05% win: 60% σ: 14.67% n: 5 2022-04-12 → 2026-07-31 | AVXL Jun avg: 1.95% median: 3.94% win: 60% σ: 15.44% n: 5 2022-04-12 → 2026-07-31 | AVXL Jul avg: 18.75% median: 6.18% win: 100% σ: 25.11% n: 5 2022-04-12 → 2026-07-31 | AVXL Aug avg: -9.22% median: -8.97% win: 0% σ: 4.72% n: 4 2022-04-12 → 2026-07-31 (current) | AVXL Sep avg: -5.70% median: -6.66% win: 25% σ: 10.18% n: 4 2022-04-12 → 2026-07-31 | AVXL Oct avg: 2.30% median: 3.05% win: 50% σ: 17.34% n: 4 2022-04-12 → 2026-07-31 | AVXL Nov avg: -1.84% median: 0.84% win: 50% σ: 45.23% n: 4 2022-04-12 → 2026-07-31 | AVXL Dec avg: 10.15% median: 9.26% win: 75% σ: 15.21% n: 4 2022-04-12 → 2026-07-31 |